Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Oral Cavity Squamous Cell Carcinoma”

289 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 289 results

Testing effectiveness (Phase 2)Study completedNCT00084682
What this trial is testing

Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Stage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the LarynxStage IV Squamous Cell Carcinoma of the Lip and Oral Cavity+1 more
National Cancer Institute (NCI) 14
Large-scale testing (Phase 3)Study completedNCT00002670
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 459
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07783581
What this trial is testing

Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial

Who this might be right for
Locally Advanced Oral Cavity Squamous Cell CarcinomaLocally Recurrent Oral Cavity Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma
Mayo Clinic 30
Not applicableStudy completedNCT00002695
What this trial is testing

Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck

Who this might be right for
Head and Neck Cancer
ECOG-ACRIN Cancer Research Group 530
Testing effectiveness (Phase 2)Ended earlyNCT02068157
What this trial is testing

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous CarcinomaRecurrent Lip and Oral Cavity Squamous Cell Carcinoma+4 more
Roswell Park Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT00003580
What this trial is testing

Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerOral Complications+1 more
University of Tennessee
Testing effectiveness (Phase 2)Study completedNCT01256385
What this trial is testing

Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+33 more
National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Study completedNCT00024089
What this trial is testing

Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT03076281
What this trial is testing

Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
LarynxLIPOral Cavity+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 7
Testing effectiveness (Phase 2)Looking for participantsNCT05862168
What this trial is testing

Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial

Who this might be right for
Oral Squamous Cell Carcinoma
Weijia Fang, MD 30
Testing effectiveness (Phase 2)Ended earlyNCT00195078
What this trial is testing

Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Weill Medical College of Cornell University 29
Testing effectiveness (Phase 2)Study completedNCT00458978
What this trial is testing

Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+20 more
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Study completedNCT01341535
What this trial is testing

Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer.

Who this might be right for
Primary Non-operated Squamous Cell Carcinoma of Oral CavityPrimary Non-operated Squamous Cell Carcinoma of OropharynxPrimary Non-operated Squamous Cell Carcinoma of Hypopharynx+1 more
University Hospital, Ghent 100
Testing effectiveness (Phase 2)Study completedNCT01316757
What this trial is testing

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+20 more
Fox Chase Cancer Center 24
Not applicableUnknownNCT01210872
What this trial is testing

Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy

Who this might be right for
Head and Neck Cancer
Centre Georges Francois Leclerc 200
Testing effectiveness (Phase 2)Ended earlyNCT01192815
What this trial is testing

Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck

Who this might be right for
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+9 more
Case Comprehensive Cancer Center 2
Large-scale testing (Phase 3)Study completedNCT00017511
What this trial is testing

Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral ComplicationsRadiation Toxicity
Daiichi Sankyo
Very early researchNot Yet RecruitingNCT07028918
What this trial is testing

A Prospective Single-Arm Study（NCLDR）

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)
Qilu Hospital of Shandong University 35
Testing effectiveness (Phase 2)Study completedNCT00058006
What this trial is testing

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT04541355
What this trial is testing

Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin

Who this might be right for
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Advanced Head and Neck Squamous Cell Carcinoma+26 more
Hyunseok Kang, MD
Next Page
16